The Effects of Donepezil in Alzheimer’s Disease – Results from a Multinational Trial1
暂无分享,去创建一个
H.-J. Möller | M. Rossor | S. Gauthier | H. Petit | A. Burns | L. Friedhoff | J. Hecker | S. Gauthier | H. Petit | S.L. Rogers | A. Burns | M. Rossor | J. Hecker | L.T. Friedhoff | M. Rossor | H. Möller | H. Möller | S. Rogers | A. Burns
[1] M. Sano,et al. An Inventory to Assess Activities of Daily Living for Clinical Trials in Alzheimer's Disease , 1997, Alzheimer disease and associated disorders.
[2] Arvind Rehalia,et al. The health centre. , 1977, Nursing times.
[3] T. H. Blau. Quality of life, social indicators, and criteria of change. , 1977 .
[4] W. G. Cochran. Some Methods for Strengthening the Common χ 2 Tests , 1954 .
[5] L. Friedhoff,et al. Long-term efficacy and safety of donepezil in the treatment of Alzheimer's disease: an interim analysis of the results of a US multicentre open label extension study , 1998, European Neuropsychopharmacology.
[6] L. Friedhoff,et al. Pharmacokinetic and pharmacodynamic profile of donepezil HCl following single oral doses. , 1998, British journal of clinical pharmacology.
[7] S H Ferris,et al. Validity and reliability of the Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change. The Alzheimer's Disease Cooperative Study. , 1997, Alzheimer disease and associated disorders.
[8] Y. Yamanishi,et al. E2020 - THE PHARMACOLOGY OF A PIPERIDINE CHOLINESTERASE INHIBITOR , 1991 .
[9] H. van Crevel,et al. Assessing the severity of dementia. Patient and caregiver. , 1991, Archives of neurology.
[10] L. Friedhoff,et al. Concurrent administration of donepezil HCl and ketoconazole: assessment of pharmacokinetic changes following single and multiple doses. , 2002, British journal of clinical pharmacology.
[11] L. Friedhoff,et al. Pharmacokinetic and pharmacodynamic profile of donepezil HCl following evening administration. , 1998, British journal of clinical pharmacology.
[12] R. Mohs,et al. Donepezil improves cognition and global function in Alzheimer disease: a 15-week, double-blind, placebo-controlled study. Donepezil Study Group. , 1998, Archives of internal medicine.
[13] Gary L. Wenk,et al. The Nucleus Basalis Magnocellularis Cholinergic System: One Hundred Years of Progress , 1997, Neurobiology of Learning and Memory.
[14] Rogers Sl,et al. Pharmacokinetic and pharmacodynamic profile of donepezil HCl following multiple oral doses , 1998 .
[15] K. Davis,et al. A new rating scale for Alzheimer's disease. , 1984, The American journal of psychiatry.
[16] I. Bross. How to use Ridit Analysis , 1958 .
[17] J. Morris,et al. Validity and Reliability of the Alzheimer's Disease Cooperative Study‐Clinical Global Impression of Change , 2017 .
[18] H. Ogura,et al. Inhibitory Action of E2020, a Novel Acetylcholinesterase Inhibitor, on Cholinesterase: Comparison with Other Inhibitors , 1990 .
[19] L. Friedhoff,et al. Pharmacokinetic and pharmacodynamic profile of donepezil HCl following multiple oral doses. , 1998, British journal of clinical pharmacology.
[20] J. Morris,et al. Validity and Reliability of the Alzheimer’s Disease Cooperative Study-Clinical Global Impression of Change (ADCS-CGIC) , 1997 .
[21] J. Rabe-Jabłońska,et al. [Affective disorders in the fourth edition of the classification of mental disorders prepared by the American Psychiatric Association -- diagnostic and statistical manual of mental disorders]. , 1993, Psychiatria polska.
[22] R. Mohs,et al. A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease , 1998, Neurology.
[23] A. Ohnishi,et al. Pharmacokinetics of E2020, a new compound for Alzheimer's disease, in healthy male volunteers. , 1993, International journal of clinical pharmacology, therapy, and toxicology.
[24] S. Folstein,et al. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.
[25] C. P. Hughes,et al. A New Clinical Scale for the Staging of Dementia , 1982, British Journal of Psychiatry.
[26] L. Friedhoff,et al. The efficacy and safety of donepezil in patients with Alzheimer's disease: Results of a US multicentre, randomized, double-blind, placebo-controlled trial , 1996 .
[27] L. Friedhoff,et al. Concurrent administration of donepezil HCl and cimetidine: assessment of pharmacokinetic changes following single and multiple doses. , 1998, British journal of clinical pharmacology.
[28] M. Folstein,et al. Clinical diagnosis of Alzheimer's disease , 1984, Neurology.
[29] J. Baty,et al. Mild senile dementia of the Alzheimer type. 4. Evaluation of intervention , 1992, Annals of neurology.
[30] D. Ridley,et al. Cape Town, South Africa , 1986, Journal of clinical ultrasound : JCU.